Imprese · 04/12/20121 min di lettura
Guidance on Investigational New Drug Applications for Positron Emission Tomography Drugs; Availability
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs." The guidance is intended to assist manufacturers of PET drugs in submitting investigational new drug applications (INDs).